Toll-like receptor 4 blocker as potential therapy for acetaminophen-induced organ failure in mice

Salama,Mohamed; Elgamal,Mohamed; Abdelaziz,Azza; Ellithy,Moataz; Magdy,Dina; Ali,Lina; Fekry,Emad; Mohsen,Zinab; Mostafa,Mariam; Elgamal,Hoda; Sheashaa,Hussein; Sobh,Mohamed

doi:10.3892/etm.2015.2442

Toll-like receptor 4 blocker as potential therapy for acetaminophen-induced organ failure in mice

Authors:
- Mohamed Salama
- Mohamed Elgamal
- Azza Abdelaziz
- Moataz Ellithy
- Dina Magdy
- Lina Ali
- Emad Fekry
- Zinab Mohsen
- Mariam Mostafa
- Hoda Elgamal
- Hussein Sheashaa
- Mohamed Sobh
View Affiliations

Affiliations: Medical Experimental Research Center, Faculty of Medicine, Mansoura University, Mansoura 36511, Egypt, Mansoura‑Manchester Programme, Faculty of Medicine, Mansoura University, Mansoura 36511, Egypt, Pathology Department, Faculty of Medicine, Mansoura University, Mansoura 36511, Egypt, Toxicology Department, Faculty of Medicine, Mansoura University, Mansoura 36511, Egypt, Urology and Nephrology Center, Faculty of Medicine, Mansoura University, Mansoura 36511, Egypt
Published online on: April 22, 2015 https://doi.org/10.3892/etm.2015.2442
Pages: 241-246

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Acetaminophen (APAP, 4-hydroxyacetanilide) is the most common cause of acute liver failure in the United States. In addition to exhibiting hepatotoxicity, APAP exerts a nephrotoxic effect may be independent of the induced liver damage. Toll‑like receptors (TLRs) have been suggested as a potential class of novel therapeutic targets. The aim of the present study was to investigate the potential of the TLR‑4 blocker TAK-242 in the prevention of APAP‑induced hepato‑renal failure. Four groups of C57BL mice were studied: Vehicle‑treated/control (VEH), APAP‑treated (APAP), N‑acetyl cysteine (NAC)‑pretreated plus APAP (APAP + NAC) and TAK‑242‑pretreated plus APAP (APAP + TAK) groups. Mice were clinically assessed then perfused 4 h later. Liver and kidney tissues were collected and examined histologically using basic hematoxylin and eosin staining to detect signs of necrosis and inflammation. Plasma samples were collected to measure the levels of alanine transaminase, aspartate transaminase and serum creatinine. In addition, liver and kidney tissues were assayed to determine the levels of reduced glutathione. The results of the present study indicate the potential role of TLR‑4 in APAP‑induced organ toxicity. In the APAP + TAK and APAP + NAC groups, histopathological examination indicated that pretreatment with TAK-242 or NAC afforded protection against APAP‑induced injury. However, this protective effect was more clinically evident in the APAP + TAK group compared with the APAP + NAC group. The various biochemical parameters (serum enzymes and reduced glutathione) revealed no significant protection in either of the pretreated groups. Therefore, the present study indicated that the TLR‑4 blocker had protective effects against acute APAP toxicity in liver and kidney tissues. These effects were identified clinically, histologically and biochemically. Furthermore, the TLR‑4 blocker TAK-242 exhibited antioxidant properties in addition to anti-inflammatory effects.

View Figures

View References

1	Abboud G and Kaplowitz N: Drug-induced liver injury. Drug Saf. 30:277–294. 2007. View Article : Google Scholar : PubMed/NCBI
2	Tujios S and Fontana RJ: Mechanisms of drug-induced liver injury: From bedside to bench. Nat Rev Gastroenterol Hepatol. 8:202–211. 2011. View Article : Google Scholar : PubMed/NCBI
3	Nourjah P, Ahmad SR, Karwoski C and Willy M: Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf. 15:398–405. 2006. View Article : Google Scholar : PubMed/NCBI
4	Mitchell JR, Jollow DJ, Potter WZ, Gillette JR and Brodie BB: Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther. 187:211–217. 1973.PubMed/NCBI
5	Terneus MV, Kiningham KK, Carpenter AB, Sullivan SB and Valentovic MA: Comparison of S-adenosyl-L-methionine and N-acetylcysteine protective effects on acetaminophen hepatic toxicity. J Pharmacol Exp Ther. 320:99–107. 2007. View Article : Google Scholar : PubMed/NCBI
6	Cermik H, Taslipinar MY, Aydin I, et al: The relationship between N-acetylcysteine, hyperbaric oxygen and inflammation in a rat model of acetaminophen-induced nephrotoxicity. Inflammation. 36:1145–1152. 2013. View Article : Google Scholar : PubMed/NCBI
7	McGill MR and Jaeschke H: Metabolism and disposition of acetaminophen: Recent advances in relation to hepatotoxicity and diagnosis. Pharm Res. 30:2174–2187. 2013. View Article : Google Scholar : PubMed/NCBI
8	Jaeschke H, McGill MR and Ramachandran A: Oxidant stress, mitochondria and cell death mechanisms in drug-induced liver injury: Lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev. 44:88–106. 2012. View Article : Google Scholar : PubMed/NCBI
9	Jaeschke H and Bajt ML: Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci. 89:31–41. 2006. View Article : Google Scholar : PubMed/NCBI
10	Arslan F, Keogh B, McGuirk P and Parker AE: TLR2 and TLR4 in ischemia reperfusion injury. Mediators Inflamm. 2010:7042022010. View Article : Google Scholar : PubMed/NCBI
11	Zager RA, Johnson AC, Lund S and Randolph-Habecker J: Toll like receptor (TLR4) shedding and depletion: acute proximal tubular cell responses to hypoxic and toxic injury. Am J Physiol. Renal Physiol. 292:F304–F312. 2007. View Article : Google Scholar : PubMed/NCBI
12	Hayashi F, Smith KD, Ozinsky A, et al: The innate immune response to bacterial ﬂagellin is mediated by Toll-like receptor 5. Nature. 410:1099–1103. 2001. View Article : Google Scholar : PubMed/NCBI
13	Kobayashi K, Hernandez LD, Galán JE, Janeway CA Jr, Medzhitov R and Flavell RA: IRAK-M is a negative regulator of Toll-like receptor signaling. Cell. 110:191–202. 2002. View Article : Google Scholar : PubMed/NCBI
14	Daubeuf B, Mathison J, Spiller S, et al: TLR4/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock. J Immunol. 179:6107–6114. 2007. View Article : Google Scholar : PubMed/NCBI
15	Kanzler H, Barrat FJ, Hessel EM and Coffman RL: Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med. 13:552–559. 2007. View Article : Google Scholar : PubMed/NCBI
16	Xu J, Zhang X, Monestier M, Esmon NL and Esmon CT: Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. J Immunol. 187:2626–2631. 2011. View Article : Google Scholar : PubMed/NCBI
17	Valentovic M, Terneus M, Harmon RC and Carpenter AB: S-Adenosylmethionine (SAMe) attenuates acetaminophen hepatotoxicity in C57BL/6 mice. Toxicol Lett. 154:165–174. 2004. View Article : Google Scholar : PubMed/NCBI
18	Kao LW, Kirk MA, Furbee RB, Mehta NH, Skinner JR and Brizendine EJ: What is the rate of adverse events after oral N-acetylcysteine administered by the intravenous route to patients with suspected acetaminophen poisoning? Ann. Emerg Med. 42:741–750. 2003. View Article : Google Scholar : PubMed/NCBI
19	Shah N, Montes de Oca M, Jover-Cobos M, et al: Role of toll-like receptor 4 in mediating multiorgan dysfunction in mice with acetaminophen induced acute liver failure. Liver Transpl. 19:751–761. 2013. View Article : Google Scholar : PubMed/NCBI
20	Salama M, Farrag SM, Abulasrar SA, et al: Up-regulation of TLR-4 in the brain after ischemic kidney-induced encephalopathy in the rat. CNS Neurol Disord Drug Targets. 12:583–586. 2013. View Article : Google Scholar : PubMed/NCBI
21	Hartley DP, Kolaja KL, Reichard J and Petersen DR: 4-Hydroxynonenal and malondialdehyde hepatic protein adducts in rats treated with carbon tetrachloride: Immunochemical detection and lobular localization. Toxicol Appl Pharmacol. 161:23–33. 1999. View Article : Google Scholar : PubMed/NCBI
22	Chan JK, Roth J, Oppenheim JJ, et al: Alarmins: Awaiting a clinical response. J Clin Invest. 122:2711–2719. 2012. View Article : Google Scholar : PubMed/NCBI
23	Lugrin J, Rosenblatt-Velin N, Parapanov R and Liaudet L: The role of oxidative stress during inflammatory processes. Biol Chem. 395:203–230. 2014. View Article : Google Scholar : PubMed/NCBI
24	Latorre E, Mendoza C, Layunta E, Alcalde AI and Mesonero JE: TLR2, TLR3 and TLR4 activation specifically alters the oxidative status of intestinal epithelial cells. Cell Stress Chaperones. 19:289–293. 2014. View Article : Google Scholar : PubMed/NCBI
25	Pierre N, Deldicque L, Barbé C, Naslain D, Cani PD and Francaux M: Toll-like receptor 4 knockout mice are protected against endoplasmic reticulum stress induced by a high-fat diet. PLoS One. 8:e650612013. View Article : Google Scholar : PubMed/NCBI